PD

Pharma Dms

BE0821.606.232

Gross margin
€ 72K ↑ 3% 2025 Total € 1.04M
Profit
€ 71K ↑ 3% 2025 Total € 458K
EBITDA
€ 71K ↑ 3% 2025 Total € 867K
EBIT
€ 71K ↑ 3% 2025 Total € 586K
Net profit
€ 71K ↑ 3% 2025 Total € 458K
Capex
€ 16K 2018 Total € 145K
Assets
€ 355K ↑ 6% 2025
Equity
€ 178K 2025
Debt
€ 178K ↑ 13% 2025
Cash
€ 222K ↑ 12% 2025
Cashflow
€ 71K ↑ 3% 2025 Total € 739K
Working capital
€ 178K 2025
Current ratio
2.00 ↓ 6% 2025
Quick ratio
2.00 ↓ 7% 2025
Working capital ratio
2.00 ↓ 7% 2025
Debt
€ 178K ↑ 13% 2025
Short-term debt
€ 178K ↑ 14% 2025
Long-term debt
€ 0 ↓ 100% 2019
Debt / EBITDA
2.49 ↑ 10% 2025
Solvability
50.0% ↓ 3.1 pt 2025
Long term debt ratio
0.00 ↓ 100% 2019
Gross profitability
40.0% ↑ 1.2 pt 2025
Net profitability
40.0% ↑ 1.2 pt 2025
Return On Assets (ROA)
20.02 ↓ 3% 2025
Return On Equity (ROE)
40.04 ↑ 3% 2025
Taxes
€ 8K ↑ 97% 2025 Total € 34K
Salaries and Social Security Contributions
€ 0 ↓ 100% 2019 Total € 47K
Employees
0.60 ↑ 50% 2018
Staff cost per employee
€ 9K ↓ 12% 2018
Dividends
€ 71K ↑ 3% 2025 Total € 440K
Dividend payout
99.8% ↓ 0.2 pt 2025